<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65525">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02010138</url>
  </required_header>
  <id_info>
    <org_study_id>2013-07-083</org_study_id>
    <nct_id>NCT02010138</nct_id>
  </id_info>
  <brief_title>Extent of Internal Limiting Membrane (ILM) Affects the Outcome of Idiopathic Macular Hole Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      As removal of internal limiting membrane became one of the procedure in the standard
      treatment of idiopathic macular hole.

      The purpose of the present study was to investigate the effect of size of internal limiting
      removed on the outcome of macular hole surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Degree of foveal elongation</measure>
    <time_frame>postoperative 6months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>metamorphopsia</measure>
    <time_frame>6months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>change in visual acuity</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Idiopathic Macular Hole</condition>
  <arm_group>
    <arm_group_label>small extent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ILM removal done in a small size</description>
  </arm_group>
  <arm_group>
    <arm_group_label>large extent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ILM removal done in a large size</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>small extent of ILM removal</intervention_name>
    <description>The size of ILM that is removed during the surgery will be small, 1.5 disc diameter as a total diameter</description>
    <arm_group_label>small extent</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>large extent of ILM removal</intervention_name>
    <description>The size of ILM that is removed during the surgery will be large, 3.0 disc diameter as a total diameter.</description>
    <arm_group_label>large extent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  idiopathic macular hole

        Exclusion Criteria:

          -  macular hole associated with other causative diseases
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Se Woong Kang, MD</last_name>
    <phone>+82-2-3410-3548</phone>
    <email>swkang@skku.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Se Woong Kang, MD</last_name>
      <phone>+82-2-3410-3548</phone>
    </contact>
    <contact_backup>
      <last_name>Ga Eun Cho, MD</last_name>
      <email>gaeun.cho.oph@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Se Woong Kang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ga Eun Cho, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>December 11, 2013</lastchanged_date>
  <firstreceived_date>December 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
